3 research outputs found

    EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma

    Get PDF
    Purpose. This study investigates the efficacy and toxicity of daily oral etoposide in chemotherapy for non-heavily pretreated advanced and metastatic soft tissue sarcoma (STS)

    Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

    No full text
    corecore